1 min to read News Posted on January 28, 2023 London-listed SPAC targets merger with chronic disease drug developer Istesso – Sky News London-listed SPAC targets merger with chronic disease drug developer Istesso Sky News Source: London-listed SPAC targets merger with chronic disease drug developer Istesso – Sky News share tweet share S&P 500 2023 Outlook: Stay Alive In The First Half – Seeking Alpha5 things you really should not buy in 2023 – MorningstarReport: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPACWhat Will Crypto SPACs Look Like in 2023? Tags: SPACs